<html xmlns="http://www.w3.org/1999/xhtml" xmlns="http://www.w3.org/1999/xhtml">
 <head xmlns="http://www.w3.org/1999/xhtml">
 <title xmlns="http://www.w3.org/1999/xhtml"></title>
 </head>
 <body xmlns="http://www.w3.org/1999/xhtml">
 
 <a xmlns="http://www.w3.org/1999/xhtml" href="http://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fscott-scott.com%2Fcase%2Fjbs-s-a-2%2F&amp;esheet=51591811&amp;newsitemid=20170719006005&amp;lan=en-US&amp;anchor=Scott%2BScott%2C+Attorneys+at+Law%2C+LLP&amp;index=1&amp;md5=94c32ec60932cecb135f0e5bf5d5ec8f" rel="nofollow" rel="nofollow">Scott+Scott, 
 Attorneys at Law, LLP</a> ("Scott+Scott"), a national shareholder and 
 consumer rights litigation firm, announces that a class action lawsuit 
 has been filed against JBS S.A. JBSAY ("JBS" or the "Company") 
 and certain of its senior officers and executives regarding violation of 
 federal securities laws. If you purchased JBS American Depositary 
 Receipts ("ADRs") between June 2, 2015 and May 19, 2017, you are 
 encouraged to contact a Scott+Scott attorney at (844) 818-6980 for more 
 information. The deadline for filing lead plaintiff papers in the 
 lawsuit is July 21, 2017.
 
 
 JBS is a Brazilian food company that processes meats, such as beef, 
 pork, lamb and chicken, as well as the hides, and exports its products 
 throughout the world.
 
 
 On March 17, 2017, it was widely reported that Brazilian federal police 
 raided the offices of JBS and other meatpacking companies in a crackdown 
 on alleged bribery of health officials known as "Operation Weak Flesh." 
 In May 2017, JBS's Chairman and CEO admitted to paying high-level 
 government bribes and the President of Brazil accused the Company's 
 Chairman and CEO of insider trading.
 
 
 On June 1, 2017, The Wall Street Journal reported that JBS's holding 
 company "would pay 10.3 billion reais ($3.2 billion) over 25 years after 
 admitting to paying roughly $150 million–mostly in bribes–to 
 politicians."
 
 
 On June 9, 2017, Reuters reported that Brazil's federal police raided 
 JBS offices to investigate the alleged use of insider information in 
 financial market dealings.
 
 
 Since market close on March 16, 2017, the price of JBS ADRs has 
 plummeted over 41%.
 
 
 What You Can Do
 
 
 If you are an investor in JBS ADRs and you wish to discuss this lawsuit, 
 or have questions about this notice or your legal rights, please contact 
 attorney Rhiana Swartz at (844) 818-6980, or at <a xmlns="http://www.w3.org/1999/xhtml" href="mailto:rswartz@scott-scott.com" rel="nofollow" rel="nofollow">rswartz@scott-scott.com</a>. 
 Shareholders have until July 21, 2017 to petition the court for lead 
 plaintiff status.
 
 
 About Scott+Scott, Attorneys at Law, LLP
 
 
 Scott+Scott has significant experience in prosecuting major securities, 
 antitrust, and employee retirement plan actions throughout the United 
 States. The firm represents pension funds, foundations, individuals, and 
 other entities worldwide with offices in New York, London, Connecticut, 
 California, and Ohio.
 
 <img xmlns="http://www.w3.org/1999/xhtml" alt="" src="http://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20170719006005r1&amp;sid=benz2&amp;distro=nx&amp;lang=en"></img>View source version on businesswire.com: <a xmlns="http://www.w3.org/1999/xhtml" href="http://www.businesswire.com/news/home/20170719006005/en/" rel="nofollow" rel="nofollow">http://www.businesswire.com/news/home/20170719006005/en/</a></body></html>

Press Releases

Scott+Scott, Attorneys at Law, LLP Reminds Investors of July 21st Deadline to File Lead Plaintiff Papers in Securities Class Action Lawsuit Against JBS S.A. - JBS (OTC:JBSAY)

JBSAY

Scott+Scott, Attorneys at Law, LLP Reminds Investors of July 21st Deadline to File Lead Plaintiff Papers in Securities Class Action Lawsuit Against JBS S.A.


The Federal Home Loan Bank of Pittsburgh (FHLBank) announced today unaudited financial results for the first quarter of 2024.


Financial Highlights:



First quarter net income of $154.0 million



First quarter net

FHLBank Pittsburgh Announces First Quarter 2024 Operating Highlights


27th Annual Meeting of the American Society of Gene and Cell Therapy in Baltimore, MD on May 8, 2024


Exegenesis Bio, a rapidly growing global genetic medicines company, is pleased to announce the presentation of

Exegenesis Bio to Present 9-Patient Data from a Phase 1/2 Clinical Trial of EXG001-037, a Novel rAAV Gene Therapy for Spinal Muscular Atrophy (SMA) Type 1: Improved Head Control and Sitting Without External Assistance


AM Best has affirmed the Financial Strength Rating of A- (Excellent) and the Long-Term Issuer Credit Rating of &#34;a-&#34; (Excellent) of Tower Limited (Tower) (New Zealand). The outlook of these Credit Ratings (ratings) is

AM Best Affirms Credit Ratings of Tower Limited


Following Engagement with Proposed CEO Jim Barber and Proposed COO Jamie Boychuk, the BMWED Teamsters Decides to Express Its Opposition to the Current Leadership of Norfolk Southern


The BMWED Teamsters Concludes That

Ancora Receives Support from the Brotherhood of Maintenance of Way Employees Division of the International Brotherhood of Teamsters For A Change in Leadership at Norfolk Southern


Sees No Reason to Support the Current Administration at Norfolk Southern


The Brotherhood of Maintenance of Way Employes Division of the International Brotherhood of Teamsters (&#34;BMWED-IBT&#34;) today announced that it has

The Brotherhood of Maintenance of Way Employes Division of the International Brotherhood of Teamsters Determines that a Change in Leadership is Needed At Norfolk Southern


AM Best has revised the outlook to positive from stable for the Long-Term Issuer Credit Rating (Long-Term ICR) and affirmed the Financial Strength Rating (FSR) of A (Excellent) and the Long-Term ICR of &#34;a&#34; (Excellent)